Agilent Technologies (A): Quarterly EPS earnings growth

agilent.com - graphic logo of issuer A

Agilent Technologies management has established a model with a high proportion of recurring payments. The current quarterly EPS growth rate visualizes this trend, with the current value standing at 8.40. Revenues rely on government grants and the R&D budgets of pharma behemoths. High B2B customer loyalty and strict FDA standards ensure the stability of the laboratory analysis ecosystem.

agilent.com (A) Year-over-year earnings per share growth for the last twelve months: for the period 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for Agilent Corp (A)

- share price and expert price forecast:
Fundamental company valuation:Agilent, A
Manufactured product of agilent.com

To protect capital, it is essential to decouple an asset's fundamental stability from short-term market volatility. This indicator captures the rolling growth of earnings per share over the last three months. Analyzing quarterly earnings per share dynamics allows for the identification of the actual pace of value generation. The stability of this trend for Agilent Technologies (A) is driven by a significant share of recurring service payments. Such a model minimizes the impact of macroeconomic shocks on financial results.

Who Agilent Technologies competes with

DGX: Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Illumina Inc ILMN|EXAS (Cologuard) - Quarterly EPS earnings growth|Revvity Corp (RVTY) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Bio-Rad Laboratories (BIO)|Year-over-year earnings per share growth for the last twelve months NNNN (anbio.com)|Quarterly EPS earnings growth SHC (Sotera Health)|Quidel Corporation (QDEL) - Earnings per share growth in annualized terms for the last twelve months|OPK - Year-over-year earnings per share growth for the last twelve months|CDNA (CareDx, Inc) - Year-over-year earnings per share growth for the last 12 months|MRVI (Maravai LifeSciences) - Year-over-year net earnings per share growth for the last 12 months|FLGT: Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months LAB|CTKB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months OSUR (OraSure Technologies Inc)|Year-over-year earnings per share growth rate for the last twelve months XGN|Quarterly EPS earnings growth MDXH (MDxHealth SA)|luciddx.com (LUCD) - Earnings per share growth in annualized terms for the last twelve months|Prenetics Global Ltd - Quarterly EPS earnings growth|Insight Molecular Diagnostics (IMDX) - Year-over-year net earnings per share growth for the last 12 months|TRIB: Quarterly EPS earnings growth|ProPhase Labs Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Ainos, Inc.|Year-over-year earnings per share growth for the last 12 months CODX (codiagnostics.com)|Year-over-year earnings per share growth for the last twelve months HeartSciences (HSCS)|BMRA - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Cardio Diagnostics Holdings CDIO|Onconetix Corporation - Year-over-year earnings per share growth for the last twelve months|VRAX - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months bluejaydx.com|AWH: Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Accelerate Diagnostics Inc. AXDX|CNTG (CENTOGENE) - Quarterly EPS earnings growth|Enzo (ENZ) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth FRES|GENE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months 23andMe ME|Year-over-year net earnings per share change for the last twelve months Psychemedics Corp. (PMD)